Abstract Click to copy section linkSection link copied! Bafilomycin and concanamycin analogs (1-3) are microbial natural products with potent V-ATPase inhibitory activity. Despite their promising therapeutic potential, limited access to these plecomacrolide scaffolds has constrained their broader bioactivity evaluation. Here, we report an integrative approach combining genome mining, strain engineering, and molecular networking to expand the chemical diversity of natural concanamycin analogs.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Katherine Lev
June 2026 issue first authors
TrendsTalk | Series: Meet the first authorsOnline now Affiliations & Notes 1Department of Obstetrics and Gynecology/Section of Gynecologic Oncology, Center for Integrated Science, The University of Chicago, Chicago, IL, USA 2Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, SAR, China 3Laboratory of Molecular Modeling & Drug Discovery, Istituto Italiano Di Tecnologia, Genoa 4Institute of Brain Science and Brain-inspired...
Zoliflodacin: an oral, first-in-class antibacterial agent for drug-resistant gonorrhea
Get full text access Log in, subscribe or purchase for full access. References 1. Morgan, H. ... A 2.8 Å structure of zoliflodacin in a DNA cleavage complex with Staphylococcus aureus DNA gyrase Int. J. Mol. Sci. 2023; 24:1634 2. Alm, R.A. ... Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae Antimicrob. Agents Chemother. 2015; 59:1478-1486 3. Kern, G. ...
Cyanopeptide Mixtures Induce Variable Synergistic and Antagonistic Effects Across Diverse Human Cell Lines
1 Introduction Cyanobacterial harmful algal blooms (cyanoHABs) are a growing, global threat to freshwater ecosystems and public health due to their production of toxic secondary metabolites [1-4]. Among these, only four cyanotoxins are currently monitored by federal agencies in the United States: microcystins (MCs), cylindrospermopsin, anatoxin-a, and saxitoxin [5-7].
Cyanopeptide Mixtures Induce Variable Synergistic and Antagonistic Effects Across Diverse Human Cell Lines
1 Introduction Cyanobacterial harmful algal blooms (cyanoHABs) are a growing, global threat to freshwater ecosystems and public health due to their production of toxic secondary metabolites [1-4]. Among these, only four cyanotoxins are currently monitored by federal agencies in the United States: microcystins (MCs), cylindrospermopsin, anatoxin-a, and saxitoxin [5-7].
A mechanistic neural network model predicts both potency and toxicity of antimicrobial combination therapies
SC and HSA are inventors on a patent application by UM related to drug combination toxicity prediction with deep learning. RV is an employee of Komodo Health. The authors declare that they have no other competing interests.
Ultra-high-throughput screening of antimicrobial combination therapies using a two-stage transparent machine learning model
Abstract Here, we present M2D2, a two-stage machine learning (ML) pipeline that identifies promising antimicrobial drug combinations, which are crucial for combating drug resistance. M2D2 addresses key challenges in drug combination discovery by predicting drug synergies using computationally generated drug-protein interaction data, thereby circumventing the need for expensive omics data.
Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited.
Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Experimental Therapeutics Razieh Kebriaei, Katherine L. Lev, Kyle C. Stamper, Susan M. Lehman, Sandra Morales, Michael J. Rybak DOI: 10.1128/AAC.01863-20 ABSTRACT This study aimed to test the efficacy of bacteriophage-antibiotic combinations (BACs) in vitro in 24-h time-kill settings and in ex vivo simulated endocardial vegetation (SEV) pharmacokinetic/pharmacodynamic models for 96 h.
Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities
Clinical Therapeutics Taylor Morrisette, Katherine L. Lev, Razieh Kebriaei, Jacinda C. Abdul-Mutakabbir, Kyle C. Stamper, Sandra Morales, Susan M. Lehman, Gregory S. Canfield, Breck A. Duerkop, Cesar A. Arias, Michael J. Rybak DOI: 10.1128/AAC.00993-20 ABSTRACT Concerns regarding increased prevalence of daptomycin (DAP)-resistant strains necessitate novel therapies for Enterococcus faecium infections. Obligately lytic bacteriophages are viruses that target, infect, and kill bacterial cells.
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus
Experimental Therapeutics Razieh Kebriaei, Katherine Lev, Taylor Morrisette, Kyle C. Stamper, Jacinda C. Abdul-Mutakabbir, Susan M. Lehman, Sandra Morales, Michael J. Rybak DOI: 10.1128/AAC.00461-20 ABSTRACT Comparative time-kill experiments with Staphylococcus aureus bacteriophage (phage) Sb-1 alone and phage-antibiotic combinations (PACs) against two methicillin-resistant S. aureus (MRSA) strains have shown synergy with both daptomycin-phage and vancomycin-phage combinations.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Katherine
Contact Katherine, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack